WheltonPKCareyRMAronowWSet al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/ NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2017;71:e13-e115.
2.
KannelWBWilsonPWZhangTJ. The epidemiology of impaired glucose tolerance and hypertension. Am Heart J. 1991;121:1268-1273.
3.
AdlerAIStrattonIMNeilHAet al. Association of systolic blood pressure with macrovascular and microvascu-lar complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ. 2000;321:412-419.
4.
JamesPAOparilSCarterBLet al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311:507-520.
5.
WrightJTJrWilliamsonJDWheltonPKet al. A randomized trial of intensive versus standard blood-pressure control. SPRINT Research Group. N Engl J Med. 2015;373:2103-2116.
6.
American Diabetes Association. Cardiovascular disease and risk management: Standards of Medical Care in Diabetes 2019. Diabetes Care. 2019;42(suppl 1):S103-S123.
7.
CushmanWCEvansGWByingtonRPet al. Effects of intensive blood-pressure control in type 2 diabetes mellitus. ACCORD Study Group. N Engl J Med. 2010;362: 1575-1585.
8.
GersteinHCMillerMEByingtonRPet al. Effects of intensive glucose lowering in type 2 diabetes. ACCORD Study Group. N Engl J Med. 2008;358;2545-2559.
9.
BuckleyLFDixonDLWolfordGFet al. Intensive versus standard blood pressure control in SPRINT-eligible participants of ACCORD-BP. Diabetes Care. 2017;40:1733-1738.
10.
BundyJDMillisKTChenJet al. Estimating the association of the 2017 and 2014 hypertension Guidelines With Cardiovascular Events and Deaths in US adults: analysis of national data. JAMA Cardiol. 2018;3:572-581.
